Abstract Background Interventions that promote adjuvant endocrine therapy (AET) adherence are critical to improve breast cancer survival. The development of interventions would benefit from a better understanding of the reasons for adherence and the causal relationships of determinants using theoretical or model approaches. The aim of the present study was to identify reasons for AET adherence in breast cancer patients with sequential relationships and inter-relationships. Methods A total of 210 participants with estrogen receptor positive breast cancer who received AET completed a questionnaire assessing demographic/medical, psychological, and endocrine therapy (ET)-specific factors. A descriptive analysis was performed to identify meaning...
International audiencePurpose: Despite the benefits of adjuvant endocrine therapy (AET) for reducing...
Adjuvant endocrine therapy (AET) taken for a minimum of five years reduces the recurrence and mortal...
International audienceThis study aimed to describe adjuvant endocrine therapy adherence trajectories...
We tested determinants of Adjuvant endocrine therapy (AET) adherence using patient characteristics,...
Introduction: Despite evidence of the efficacy of adjuvant endocrine therapy (AET) in reducing the r...
Introduction: Despite evidence of the efficacy of adjuvant endocrine therapy (AET) in reducing the r...
Jo Brett,1 Mary Boulton,1 Debbie Fenlon,2 Nick J Hulbert-Williams,3 Fiona M Walter,4 Peter Donnelly,...
Adherence to adjuvant endocrine therapy (AET) following breast cancer is known to be suboptimal desp...
Abstract Background Adjuvant endocrine therapy (AET) significantly decreases the risk of breast canc...
International audienceAbstract Background Adjuvant endocrine therapy (AET) is a daily oral medicatio...
Purpose: To inform intervention development, we measured the modifiable determinants of endocrine th...
Introduction : Despite evidence of the efficacy of Adjuvant Endocrine Therapy (AET) in reducing the ...
Background: Adjuvant endocrine therapy (AET) is highly efficacious, significantly reducing breast ca...
International audiencePurpose: Despite the benefits of adjuvant endocrine therapy (AET) for reducing...
Adjuvant endocrine therapy (AET) taken for a minimum of five years reduces the recurrence and mortal...
International audienceThis study aimed to describe adjuvant endocrine therapy adherence trajectories...
We tested determinants of Adjuvant endocrine therapy (AET) adherence using patient characteristics,...
Introduction: Despite evidence of the efficacy of adjuvant endocrine therapy (AET) in reducing the r...
Introduction: Despite evidence of the efficacy of adjuvant endocrine therapy (AET) in reducing the r...
Jo Brett,1 Mary Boulton,1 Debbie Fenlon,2 Nick J Hulbert-Williams,3 Fiona M Walter,4 Peter Donnelly,...
Adherence to adjuvant endocrine therapy (AET) following breast cancer is known to be suboptimal desp...
Abstract Background Adjuvant endocrine therapy (AET) significantly decreases the risk of breast canc...
International audienceAbstract Background Adjuvant endocrine therapy (AET) is a daily oral medicatio...
Purpose: To inform intervention development, we measured the modifiable determinants of endocrine th...
Introduction : Despite evidence of the efficacy of Adjuvant Endocrine Therapy (AET) in reducing the ...
Background: Adjuvant endocrine therapy (AET) is highly efficacious, significantly reducing breast ca...
International audiencePurpose: Despite the benefits of adjuvant endocrine therapy (AET) for reducing...
Adjuvant endocrine therapy (AET) taken for a minimum of five years reduces the recurrence and mortal...
International audienceThis study aimed to describe adjuvant endocrine therapy adherence trajectories...